Cannabis Use in Germany

被引:3
|
作者
Kotz, Daniel [1 ,2 ,3 ,9 ]
Kastaun, Sabrina [2 ,4 ]
Manthey, Jakob [5 ,6 ]
Hoch, Eva [7 ,8 ]
Klosterhalfen, Stephanie [1 ,2 ]
机构
[1] Heinrich Heine Univ, Inst Gen Practice Ifam, Med Fac ,Addict Res & Clin Epidemiol Unit, Ctr Hlth & Soc Chs, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Postfach 101007, D-40001 Dusseldorf, Germany
[3] UCL, Dept Behav Sci & Hlth, London, England
[4] Heinrich Heine Univ Dusseldorf, Inst Gen Practice ifam, Med Fac, Ctr Hlth & Soc Chs,Patient Phys Commun Res Unit, Dusseldorf, Germany
[5] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Interdisciplinary Addict Res ZIS, Dept Psychiat & Psychotherapy, Hamburg, Germany
[6] Univ Leipzig, Med Fac, Dept Psychiat, Leipzig, Germany
[7] IFT Inst Therapieforsch, Ctr Mental Hlth & Addict Res, Munich, Germany
[8] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Psychiat & Psychotherapy, Cannabinoid Res Grp, Munich, Germany
[9] Heinrich Heine Univ Dusseldorf, Inst Allgemeinmed Ifam, Ctr Hlth & Soc Chs,Med Fak, Schwerpunkt Suchtforsch & Klin Epidemiol, Postfach 101007, D-40001 Dusseldorf, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2024年 / 121卷 / 02期
关键词
TOBACCO; HEALTH; OUTCOMES;
D O I
10.3238/arztebl.m2023.0237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The federal government of Germany is planning to liberalize the recreational cannabis market for adults. We aimed to collect key baseline data on frequency of use, routes of administration, and co -use of cannabis and inhaled nicotine or tobacco products in the population. Methods: Based on data from a national survey of 9644 people aged >14 years, we analyzed self -reported use of cannabis in the past 12 months and preferred route of administration (single choice: smoked with tobacco; smoked without tobacco; inhaled without tobacco; consumed with food; consumed in another form). Results: The prevalence of past -year cannabis use was 4.6% (95% CI [4,2; 5,1 %]), with higher rates among 14-24- (11.4%) and 25-39 -year -olds (8.2%) as well as among co -users of inhaled nicotine or tobacco products, particularly waterpipe users (27.0%). Smoking cannabis with or without tobacco was the preferred route of administration, reported by 92.4% (95% CI [89,6; 94,6%]). It was most frequently reported by 14-24 -year -olds and by co -users of inhaled nicotine or tobacco products. Conclusion: Smoking remains the predominant form of using cannabis-especially among younger users, who are at greatest risk of cannabis -related consequences. The true prevalence of cannabis use may have been underestimated in our study, however, as not all participants answered the questions on cannabis. Nevertheless, preventive and harm reduction efforts are needed to reduce the harm from using cannabis. Continuous monitoring is required to evaluate the effects of the forthcoming law changes in Germany.
引用
收藏
页码:52 / 57
页数:9
相关论文
共 50 条
  • [1] The medical use of cannabis in Germany
    Grotenhermen, F
    [J]. JOURNAL OF DRUG ISSUES, 2002, 32 (02) : 607 - 633
  • [2] Use and Assessment of Cannabis in the Population of Germany
    Eul, J.
    Stoever, H.
    [J]. SUCHTTHERAPIE, 2012, 13 (04) : 177 - 184
  • [3] The use of cannabis in the Federal Republic of Germany
    Tossmann, Peter
    [J]. PRAXIS DER KINDERPSYCHOLOGIE UND KINDERPSYCHIATRIE, 2006, 55 (07) : 509 - 519
  • [4] Controlled Delivery of Cannabis for Recreational Use ("Cannabis Legalization") in Germany
    Havemann-Reinecke, Ursula
    [J]. SUCHT-ZEITSCHRIFT FUR WISSENSCHAFT UND PRAXIS, 2022, 68 (06): : 351 - 353
  • [5] Germany considers legalising cannabis for medical use
    Stafford, Ned
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [6] Cannabis for medical use - implementation of a new regulation in Germany
    Knoess, W.
    Heldt, C.
    Ledderhose, C.
    Otting, H.
    Retterath, R.
    [J]. PLANTA MEDICA, 2021, 87 (15) : 1283 - 1283
  • [7] Patterns of concurrent alcohol, tobacco, and cannabis use in Germany: Prevalence and correlates
    Hoehne, Birgit
    Pabst, Alexander
    Hannemann, Tessa-Virginia
    Kraus, Ludwig
    [J]. DRUGS-EDUCATION PREVENTION AND POLICY, 2014, 21 (02) : 102 - 109
  • [8] Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey
    Montagnese, Federica
    White, Molly
    Klein, Anke
    Stahl, Kristina
    Wenninger, Stephan
    Schoser, Benedikt
    [J]. JOURNAL OF NEUROLOGY, 2019, 266 (02) : 530 - 532
  • [9] Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey
    Federica Montagnese
    Molly White
    Anke Klein
    Kristina Stahl
    Stephan Wenninger
    Benedikt Schoser
    [J]. Journal of Neurology, 2019, 266 : 530 - 532
  • [10] Cannabis use and cannabis use disorders
    Hoch, E.
    Preuss, U. W.
    [J]. NERVENARZT, 2024, 95 (09): : 781 - 796